NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

PRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.

Canadian Journal of Neurological Sciences, published by Cambridge University Press, stands as a reputable source of knowledge in the field of neurology, dedicated to advancing research and clinical practice. With an ISSN of 0317-1671 and an E-ISSN of 2057-0155, this journal has been a cornerstone for the exchange of ideas since its inception in 1974 and will continue to cater to the academic community until 2024. Recognized in the top quartile (Q2) in various categories including Medicine (miscellaneous) and Neurology (clinical), its articles engage a broad audience, ranging from established researchers to students seeking to deepen their understanding of neurological sciences. Although the journal is not an open-access publication, it provides vital insights and research findings that contribute significantly to its fields. With a Scopus rank of #183 in clinical neurology and a percentile ranking that reflects its commendable standing, the Canadian Journal of Neurological Sciences is indispensable for those committed to the exploration and treatment of neurological disorders.

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.

Current Treatment Options in Neurology, published by CURRENT MEDICINE GROUP, is a pivotal journal in the field of clinical neurology, dedicated to enhancing the understanding and management of neurological disorders. With a print ISSN of 1092-8480 and an E-ISSN of 1534-3138, this journal serves as a vital resource for clinicians, researchers, and students alike, providing evidence-based insights and treatment strategies from its continuous publication since its inception in 1999. It currently holds a respectable rank in the Q3 quartile, reflecting its competitive standing in the Scopus rankings for clinical neurology, placing it at the 51st percentile. Although not classified as Open Access, the journal continues to provide valuable contributions that inform clinical practices and improve patient outcomes in neurological care. With its comprehensive reviews and clinical focus, Current Treatment Options in Neurology remains an essential platform for disseminating the latest advancements in treatment methodologies and therapeutic options, solidifying its importance in the ever-evolving landscape of neurology.

Future Neurology, published by Future Medicine Ltd, is an emerging peer-reviewed journal dedicated to the rapidly evolving field of neurology, with a keen focus on both clinical and translational research. Since its inception in 2007, the journal has provided a unique platform for sharing innovative findings and fostering collaboration among neurologists, neuroscientists, and healthcare professionals. Although currently categorized in the Q4 quartile for both Neurology and Clinical Neurology, Future Neurology strives to improve its impact factor by publishing high-quality research and reviews that address pressing issues in neurological health. With its commitment to disseminating knowledge, the journal serves as an essential resource for professionals and researchers seeking to stay informed about advancements in neurological science. It is particularly valuable for those looking to contribute to and engage with the latest developments in neurotherapeutics, diagnostics, and patient care strategies. The journal is indexed in major databases and is available in print and online formats, ensuring wider accessibility to its content for all stakeholders in the field.

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

The Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.